Elevance Health (ELV) Treasury Shares (2009 - 2026)

Elevance Health (ELV) has 18 years of Treasury Shares data on file, last reported at $1.6 million in Q1 2026.

• Quarterly Treasury Shares rose 33.33% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 33.33% YoY) and the FY2025 annual result came in at $1.1 million, up 10.0% from the prior year.
• Treasury Shares advanced to $1.6 million in Q1 2026 per ELV's latest filing, from $1.1 million in the prior quarter.
• Across five years, Treasury Shares topped out at $1.6 million in Q1 2026 and bottomed at $1.0 million in Q3 2024.
• The 5-year median for Treasury Shares is $1.1 million (2023), against an average of $1.2 million.
• The widest annual swing landed in 2024, when Treasury Shares decreased 9.09%; it then jumped 33.33% in 2026.
• Tracing ELV's Treasury Shares over 5 years: stood at $1.2 million in 2022, then slipped by 8.33% to $1.1 million in 2023, then retreated by 9.09% to $1.0 million in 2024, then rose by 10.0% to $1.1 million in 2025, then jumped by 45.45% to $1.6 million in 2026.
• Per Business Quant, the three latest ELV Treasury Shares figures stand at $1.6 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025).

Peer Comparison